Triveni Bio

Triveni Bio is a biotechnology company developing novel antibody treatments for immunological and inflammatory disorders. They utilize a genetics-informed, precision medicine approach to establish proof-of-concept early in drug development. Their focus is on creating innovative combinations to enhance treatment outcomes for conditions lacking adequate standard of care.


Buy Funded Startups lists

Funding Round: Series B

Funding Amount: $115M

Date: 02-Oct-2024

Investors: Goldman Sachs Alternatives, Fidelity Management & Research Company, Deep Track Capital, Atlas Venture, Cormorant Asset Management, OrbiMed, Viking Global Investors, Invus

Markets: Biotechnology, Immunology, Inflammatory Disorders

HQ: Watertown, Massachusetts, United States

Founded: 2019

Website: https://www.triveni.bio

LinkedIn: https://www.linkedin.com/company/triveni-bio

Twitter:

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/triveni-bio

Pitchbook: https://pitchbook.com/profiles/company/539030-35


Leave a Comment